[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium

C49H52NO16PY-2 — CID 59927477

IUPAC[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium
SMILESCC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O[C-]=O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](OP)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C.[CH-]=O.[Y]
InChIInChI=1S/C48H51NO15P.CHO.Y/c1-26-32(61-44(56)38(64-65)36(29-16-10-7-11-17-29)49-42(54)30-18-12-8-13-19-30)23-48(57)41(62-43(55)31-20-14-9-15-21-31)39-46(6,40(53)37(60-27(2)51)35(26)45(48,4)5)33(59-25-50)22-34-47(39,24-58-34)63-28(3)52;1-2;/h7-21,32-34,36-39,41,57H,22-24,65H2,1-6H3,(H,49,54);1H;/q2*-1;/t32-,33-,34+,36-,37+,38+,39-,41-,46+,47-,48+;;/m0../s1
InChIKeyXCTAQPVDBGANSY-MOEQYALBSA-N
MW1030.83 g/mol
LogP4.36
Rot. Bonds13

About [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium

[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium (PubChem CID 59927477) has the molecular formula C49H52NO16PY-2 and a molecular weight of 1030.83 g/mol. Its IUPAC name is [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium.

Molecular Properties

Compound Name[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium
PubChem CID59927477
Molecular FormulaC49H52NO16PY-2
Molecular Weight1030.83 g/mol
Exact Mass1030.21
IUPAC Name[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium
SMILESCC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O[C-]=O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](OP)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C.[CH-]=O.[Y]
InChIInChI=1S/C48H51NO15P.CHO.Y/c1-26-32(61-44(56)38(64-65)36(29-16-10-7-11-17-29)49-42(54)30-18-12-8-13-19-30)23-48(57)41(62-43(55)31-20-14-9-15-21-31)39-46(6,40(53)37(60-27(2)51)35(26)45(48,4)5)33(59-25-50)22-34-47(39,24-58-34)63-28(3)52;1-2;/h7-21,32-34,36-39,41,57H,22-24,65H2,1-6H3,(H,49,54);1H;/q2*-1;/t32-,33-,34+,36-,37+,38+,39-,41-,46+,47-,48+;;/m0../s1
InChIKeyXCTAQPVDBGANSY-MOEQYALBSA-N
XLogP4.36
TPSA233.43 Ų
H-Bond Donors2
H-Bond Acceptors16
Rotatable Bonds13
Heavy Atoms68
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001030.83
LogP ≤ 54.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium?
The IUPAC name of [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium (CID 59927477) is [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium.
What is the SMILES notation for [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium?
The canonical SMILES for [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium is CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O[C-]=O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](OP)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C.[CH-]=O.[Y].
What is the InChIKey of [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium?
The InChIKey is XCTAQPVDBGANSY-MOEQYALBSA-N. The full InChI is InChI=1S/C48H51NO15P.CHO.Y/c1-26-32(61-44(56)38(64-65)36(29-16-10-7-11-17-29)49-42(54)30-18-12-8-13-19-30)23-48(57)41(62-43(55)31-20-14-9-15-21-31)39-46(6,40(53)37(60-27(2)51)35(26)45(48,4)5)33(59-25-50)22-34-47(39,24-58-34)63-28(3)52;1-2;/h7-21,32-34,36-39,41,57H,22-24,65H2,1-6H3,(H,49,54);1H;/q2*-1;/t32-,33-,34+,36-,37+,38+,39-,41-,46+,47-,48+;;/m0../s1.
What are the key properties of [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium?
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium has a molecular weight of 1030.83 g/mol, XLogP of 4.36, 13 rotatable bonds, 2 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phosphanyloxypropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-(oxomethoxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;methanone;yttrium is sourced from PubChem (CID 59927477), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).